Article metrics

Download PDFPDF

Original research
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial

 

Online download statistics by month:

Online download statistics by month: October 2022 to December 2022

AbstractFullPdf
Oct 202226426497
Nov 2022763754231
Dec 2022195374195375581
Total196401196393909